EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis

Min-Hsiang Chuang, Yu-Shuo Tang, Jui-Yi Chen, Heng-Chih Pan, Hung-Wei Liao, Wen-Kai Chu, Chung-Yi Cheng, Vin-Cent Wu, Michael Heung

Diabetes & Metabolism Journal · 31.03.2024 · 48 (2) · 242-252

DOI: 10.4093/dmj.2023.0201 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 31.03.2024. Verfasst von Min-Hsiang Chuang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Cardiovascular Diseases, Heart Failure. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2i) typically leads to a reversible initial dip in estimated glomerular filtration rate (eGFR). The implications of this phenomenon on clinical outcomes are not well-defined.

Methods

We searched MEDLINE, Embase, and Cochrane Library from inception to March 23, 2023 to identify randomized controlled trials and cohort studies comparing kidney and cardiovascular outcomes in patients with and without initial eGFR dip after initiating SGLT2i. Pooled estimates were calculated using random-effect meta-analysis.

Results

We included seven studies in our analysis, which revealed that an initial eGFR dip following the initiation of SGLT2i was associated with less annual eGFR decline (mean difference, 0.64; 95% confidence interval [CI], 0.437 to 0.843) regardless of baseline eGFR. The risk of major adverse kidney events was similar between the non-dipping and dipping groups but reduced in patients with a ≤10% eGFR dip (hazard ratio [HR], 0.915; 95% CI, 0.865 to 0.967). No significant differences were observed in the composite of hospitalized heart failure and cardiovascular death (HR, 0.824; 95% CI, 0.633 to 1.074), hospitalized heart failure (HR, 1.059; 95% CI, 0.574 to 1.952), or all-cause mortality (HR, 0.83; 95% CI, 0.589 to 1.170). The risk of serious adverse events (AEs), discontinuation of SGLT2i due to AEs, kidney-related AEs, and volume depletion were similar between the two groups. Patients with >10% eGFR dip had increased risk of hyperkalemia compared to the non-dipping group.

Conclusion

Initial eGFR dip after initiating SGLT2i might be associated with less annual eGFR decline. There were no significant disparities in the risks of adverse cardiovascular outcomes between the dipping and non-dipping groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsCardiovascular DiseasesHeart FailureHumansGlomerular Filtration RateGlucoseSodium

Stichwörter der Autor:innen

Diabetes mellitus, type 2Glomerular filtration rateKidneySodium-glucose transporter 2 inhibitors

Substanzen

Sodium-Glucose Transporter 2 InhibitorsGlucoseSodium

Autor:innen und Institutionen

  • Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
  • Taipei Medical University Research Center of Urology and Kidney, Taipei, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

Zitieren

APA

Chuang, M. H., Tang, Y. S., Chen, J. Y., Pan, H. C., Liao, H. W., Chu, W. K., Cheng, C. Y., Wu, V. C., & Heung, M. (2024). Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal, 48(2), 242-252. https://doi.org/10.4093/dmj.2023.0201

Vancouver

Chuang MH, Tang YS, Chen JY, Pan HC, Liao HW, Chu WK, et al. Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal. 2024;48(2):242-252. doi:10.4093/dmj.2023.0201

BibTeX
@article{Chuang2024,
  author = {Chuang, Min-Hsiang and Tang, Yu-Shuo and Chen, Jui-Yi and Pan, Heng-Chih and Liao, Hung-Wei and Chu, Wen-Kai and Cheng, Chung-Yi and Wu, Vin-Cent and Heung, Michael},
  title = {Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  volume = {48},
  number = {2},
  pages = {242--252},
  doi = {10.4093/dmj.2023.0201}
}
Kostenlos starten →